Current Cancer Therapy Reviews

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology
Witten/Herdecke University
Stockumerstraße 10, 58448 Witten
Germany

Back

Become EABM
Become Reviewer

HPV and Therapeutic Vaccines: Where are We in 2010?

Volume:6   Issue: 2
Pp: 81-103
Barbara Ma, Yijie Xu, Chien-Fu Hung and T.-C. Wu
DOI: 10.2174/157339410791202583

HPV Screening: Available Data and Recommendations for Clinical Practice

Volume:6   Issue: 2
Pp: 104-109
Guglielmo Ronco and Chris J.L.M. Meijer
DOI: 10.2174/157339410791202556

The Discovery of HPV and its Clinical Implications

Volume:6   Issue: 2
Pp: 117-119
Lutz Gissmann
DOI: 10.2174/157339410791202538

HPV Vaccination in Women Above 25 Years: Reasons Why?

Volume:6   Issue: 2
Pp: 120-125
W. Poppe, PH. Simon, W. Tjalma and M. De Ridder
DOI: 10.2174/157339410791202547

Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine open access plus

Volume:6   Issue: 2
Pp: 126-137
Nathalie Garcon and Oberdan Leo
DOI: 10.2174/157339410791202574

HPV Vaccination in Adolescents: From Clinical Data to Implementation and Practice

Volume:6   Issue: 2
Pp: 138-142
Franco Borruto and Karel Hoppenbrouwers
DOI: 10.2174/157339410791202592

Chemoprevention of Colorectal Cancer: Progress or Pipedream?

Volume:6   Issue: 2
Pp: 143-156
Rutger J. Jacobs, Liudmila L. Kodach and James C.H. Hardwick
DOI: 10.2174/157339410791202510

MicroRNAs in Cancer Therapy: From Bench to Bedside

Volume:6   Issue: 2
Pp: 157-162
Srikumar Sengupta and Anupam Bishayee
DOI: 10.2174/157339410791202501

Therapeutic Cancer Vaccines

Volume:6   Issue: 2
Pp: 163-174
Stine Kiaer Larsen, Inge Marie Svane, Per thor Straten and Mads Hald Andersen
DOI: 10.2174/157339410791202529